Global Market for Cancer Immunotherapy Estimated at US$135.2 B in 2024 to Reach US$236.9 B by 2030

A new report from Industry Experts Inc, on "Cancer Immunotherapy," is introduced. As per this market research report, the global market for Cancer Immunotherapy is estimated at US$135.2 billion in 2024 and is anticipated to post a CAGR of 9.8% during the 2024-2030 analysis period and stand at a projected US$236.9 billion by 2030.

The global cancer immunotherapy market is primarily driven by the rising prevalence of cancer worldwide, leading to a growing demand for more effective treatment options. Oncolytic viral therapies and cancer vaccines use viruses to specifically target and destroy cancer cells, while Checkpoint inhibitors and CAR-T cell therapies are increasingly employed to treat lung cancer and melanoma. These therapies stimulate immune responses and are gaining attention due to their precise targeting and reduced side effects, further driving market demand.

The Monoclonal Antibodies segment dominates the cancer immunotherapy market, holding a projected share of 55.9% in 2024. This dominance is driven by growing R&D investments in bispecific, conjugated, and naked antigen-binding antibodies, which have created new growth opportunities in oncology therapeutics. These antibodies enhance adaptive immunity and specifically target cancer antigens, resulting in improved therapeutic outcomes with reduced side effects.


The market for cancer immunotherapy analyzed in this report on a global basis covering all major regions including North America (The United States, Canada, and Mexico), Europe (Germany, France, United Kingdom, Italy, Spain, and Rest of Europe), Asia-Pacific (Japan, China, India, South Korea, and Rest of Asia-Pacific), South America (Brazil, Argentina, and Rest of South America) and Rest of World.

The study analyzes the global market for cancer immunotherapy analyzed with respect to Product – Monoclonal Antibodies, Oncolytic Viral Therapies & Cancer Vaccines and Checkpoint Inhibitors & Immunomodulators; Application – Lung Cancer, Breast Cancer, Colorectal Cancer, Skin Cancer, Prostate Cancer, Stomach Cancer, Head & Neck Cancer and Others (Including Blood, Ovarian, Cervical, Kidney, Liver, Bladder, Pancreatic, and other cancers); and End-User – Hospitals & Clinics, Cancer Research Centers and Other End-Users (Including Ambulatory Surgical Centers (ASCs), and Homecare settings).

About Industry Experts, Inc
Industry Experts, Inc., ranks among the leading market research providers globally. The company's off-the-shelf and customized business intelligence reports offer strategic insights and valuable guidance to enable various stakeholders, such as corporate strategists, analysts, researchers and startups, among others, in obtaining valuable, crisp and unbiased current and future market data. For more information, contact us on +1-320-497-3787 or visit https://industry-experts.com/

Comments

Popular posts from this blog

Use of Antimony in Lead Acid Batteries, Flame Retardants Propelling Demand, Projected to Reach US$3.5 billion by 2030

Alzheimer's Drugs Market to Grow Rapidly by about 10% CAGR During 2024-2030 and Touch $5 billion by 2030

Industry Experts, Inc. Projects Global Market for Specialty Cellulose to Reach 2 Million Metric Tons by 2030 Driven by Cellulose Ethers and MCC